Arthritis remains one of the most common chronic conditions affecting adults in the United States. According to recent research published in Arthritis Care & Research, an estimated 24.8 million adults with doctor-diagnosed arthritis reported limitations in daily activities due to their condition in 2023. These limitations, referred to as arthritis-attributable activity limitations or AAAL, impact not only physical function but also mental health, employment, and overall quality of life. Understanding the prevalence of AAAL, the populations most affected, and strategies to reduce these limitations is crucial for public health planning and individual well-being.
Arthritis is not a single disease but a group of conditions that affect the joints, causing pain, stiffness, and swelling. Common forms include osteoarthritis, rheumatoid arthritis, gout, lupus, and fibromyalgia. In 2023, arthritis affected over 53.2 million adults in the United States, and projections suggest that by 2040, nearly 78.4 million adults will have diagnosed arthritis. Of these, approximately 34.6 million adults are expected to experience AAAL, emphasizing the growing public health challenge posed by arthritis.
The 2023 study utilized data from the National Health Interview Survey (NHIS), a nationally representative annual survey, to estimate the prevalence of AAAL among US adults. Respondents were classified as having arthritis if they reported a doctor diagnosis and were further identified as having AAAL if they indicated that arthritis limited their daily activities.
The findings indicate that the age-standardized prevalence of AAAL among adults with arthritis in 2023 was 47.8 percent. This figure means that nearly half of all adults with arthritis experience limitations in their ability to perform everyday activities such as walking, climbing stairs, or self-care. While this represents a slight decline from the 2019 age-standardized prevalence of 49.2 percent, the difference was not statistically significant, suggesting that more efforts are needed to achieve meaningful reductions in activity limitations.
AAAL prevalence varied significantly across sociodemographic and health characteristics, highlighting the unequal burden of arthritis.
Women with arthritis reported higher levels of activity limitations compared to men. In 2023, 52 percent of women with arthritis had AAAL, whereas 41.8 percent of men reported limitations. This disparity aligns with previous research showing that women often experience higher pain intensity and functional limitations due to arthritis.
Activity limitations were reported across all age groups, with adults aged 85 and older experiencing the highest prevalence at 54.8 percent. Adults aged 55 to 64 also showed a high prevalence at 51.2 percent, reflecting the cumulative impact of arthritis and other age-related conditions on mobility and function.
Socioeconomic factors played a critical role in AAAL prevalence. Adults with lower educational attainment or income experienced higher levels of activity limitations. For instance, adults with a technical school degree or some college had an age-standardized AAAL prevalence of 52.1 percent compared to 40.7 percent for adults with a college degree or higher. Income disparities were also notable, with adults near or below the poverty line showing an AAAL prevalence of 63.7 percent, emphasizing the influence of financial resources on access to health care and effective disease management.
Employment status was another significant factor in AAAL prevalence. Retired adults experienced a 71.2 percent prevalence, and adults unable to work or reporting disability had an even higher prevalence of 75.7 percent. These figures highlight the strong association between arthritis, functional limitations, and the ability to maintain employment. Adults with any form of disability reported AAAL at 76.3 percent, compared with 41 percent among adults without a disability. Veterans also experienced higher AAAL rates than nonveterans, with a prevalence of 61.1 percent.
Interestingly, AAAL prevalence did not differ significantly by race or ethnicity, although some trends were observed. For example, non-Hispanic American Indian and Alaska Native adults reported higher prevalence rates, while Asian American adults reported lower prevalence. These findings suggest that while sociodemographic factors are important, other elements such as access to care, comorbidities, and lifestyle factors may play a larger role in determining AAAL risk.
Beyond sociodemographic factors, health status strongly influenced AAAL prevalence. Adults with fair or poor self-reported health experienced a prevalence of 67.7 percent, while those reporting excellent or very good health had a lower prevalence of 29.9 percent. Smoking status also influenced AAAL, with current smokers experiencing a prevalence of 55 percent compared to 44.3 percent among adults who never smoked.
Comorbid chronic conditions were associated with particularly high prevalence of activity limitations. Adults with heart disease, cancer, or chronic obstructive pulmonary disease (COPD) had AAAL prevalence ranging from 67.3 to 75.3 percent. Mobility-related disabilities, such as difficulty walking or climbing steps, were associated with the highest prevalence at 82.1 percent. Mental health conditions, including symptoms of anxiety and depression, were also strongly linked to AAAL, with prevalence of 69.5 percent among adults screening positive for anxiety and 69 percent among adults screening positive for depression.
The comparison of NHIS data from 2019 and 2023 shows that the prevalence of AAAL has remained relatively stable. In 2019, the age-standardized prevalence was 49.2 percent, and in 2023, it was 47.8 percent. While this represents a slight decline, it does not meet the Healthy People 2030 target for AAAL, which is 46.8 percent. The consistency in prevalence over time indicates that arthritis continues to significantly impact daily functioning and that additional public health efforts are needed.
The high prevalence of AAAL underscores the importance of targeted interventions to improve the lives of adults with arthritis. Addressing AAAL requires a multi-pronged approach that includes healthcare, community-based programs, and policy initiatives.
The Centers for Disease Control and Prevention recognizes arthritis-appropriate evidence-based interventions (AAEBIs) that improve physical function and reduce pain. These programs include physical activity initiatives, self-management workshops, and structured exercise programs that are low- or no-cost. Partnerships between healthcare providers, community organizations, and national programs can help increase the reach and impact of AAEBIs.
Healthcare providers, particularly primary care physicians and rheumatologists, play a critical role in identifying and managing AAAL. Regular screening for physical activity levels and functional limitations can help tailor recommendations. Referrals to physical or occupational therapy and participation in AAEBIs can enhance mobility, reduce pain, and improve mental health outcomes. Despite these benefits, many healthcare providers do not routinely recommend AAEBIs due to lack of awareness. Increasing provider education and integrating AAEBIs into electronic health records could improve patient outcomes.
Community-based programs, such as those offered by the YMCA or local recreation centers, provide opportunities for adults with arthritis to engage in safe, structured physical activity. National initiatives such as Active People, Healthy Nation, aim to promote physical activity and can help adults with arthritis achieve functional improvements. Public health policies that support accessible exercise facilities, safe walking environments, and affordable healthcare are critical to reducing AAAL prevalence.
Efforts to reduce AAAL must consider the disparities revealed by the data. Adults with lower income, lower educational attainment, disabilities, or comorbid chronic conditions experience disproportionately high levels of activity limitations. Tailored interventions that consider financial, social, and healthcare barriers are essential to reducing these disparities. Programs that incorporate mental health support and address mobility challenges can be particularly effective in high-risk populations.
While the NHIS provides valuable national estimates, there are limitations to consider. The survey relies on self-reported doctor-diagnosed arthritis, which may be subject to recall bias or misreporting. The cross-sectional design does not allow for conclusions about causality between AAAL and sociodemographic or health factors. Additionally, the NHIS does not include adults in long-term care facilities, meaning the true prevalence of AAAL may be higher than reported. Despite these limitations, the large sample size and robust methodology provide strong evidence for public health planning.
In 2023, nearly half of adults with arthritis in the United States experienced activity limitations due to their condition. These limitations were more common among women, older adults, individuals with lower income or education, and those with comorbid chronic conditions or mental health challenges. Although a slight decline in AAAL prevalence was observed compared to 2019, the change was not statistically significant, and the Healthy People 2030 target has not been met.
Reducing AAAL requires coordinated efforts across healthcare, community programs, and public health policy. Increasing awareness and accessibility of evidence-based interventions, integrating physical activity screening into healthcare practice, and addressing socioeconomic and health disparities are key strategies. By prioritizing functional health in adults with arthritis, society can improve quality of life, enhance productivity, and reduce the long-term burden of arthritis.
The findings discussed in this article are based on the work of the authors of the original study and do not necessarily represent the official position of the Centers for Disease Control and Prevention. This blog is for informational purposes only and should not be considered medical advice. Readers are encouraged to consult healthcare professionals for personal guidance on arthritis management and treatment.
Most Accurate Healthcare AI designed for everything from admin workflows to clinical decision support.